Skip to content
healthcare.dev

Aleve

NDC 0280-0113, NAPROXEN SODIUM, tablet, from Bayer HealthCare LLC..

Product NDC
0280-0113
Status
Listed
Labeler
Bayer HealthCare LLC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA020204
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0113 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
0280-0113-010028001130110 TABLET in 1 BOTTLE (0280-0113-01)
0280-0113-02002800113021 BOTTLE in 1 CARTON (0280-0113-02) / 24 TABLET in 1 BOTTLE
0280-0113-03002800113031 BOTTLE in 1 CARTON (0280-0113-03) / 270 TABLET in 1 BOTTLE
0280-0113-04002800113041 BOTTLE in 1 CARTON (0280-0113-04) / 50 TABLET in 1 BOTTLE
0280-0113-05002800113051 BOTTLE in 1 CARTON (0280-0113-05) / 90 TABLET in 1 BOTTLE
0280-0113-06002800113061 BOTTLE in 1 CARTON (0280-0113-06) / 110 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0280-0113 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0113 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0280-0113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.